Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 30;39(12):e70769.
doi: 10.1096/fj.202500415R.

Ferroptosis as an Emerging Target in Diabetic Osteoporosis

Chenchen Li  1   2 , He Gong  1   2 , Yingying Zhang  3 , Peipei Shi  1   2 , Shuyu Liu  1   2 , Qi Zhang  1   2
Affiliations
Review

Ferroptosis as an Emerging Target in Diabetic Osteoporosis

Chenchen Li et al. FASEB J. .

Abstract

Diabetic osteoporosis (DOP), as a metabolic bone disease, leads to an increased risk of fracture in patients and imposes a huge burden on society and individuals. The microenvironment of type two diabetes mellitus (T2DM) may contribute to osteoporosis by triggering cell death in bone tissue. Ferroptosis is a novel type of regulated cell death driven by iron-dependent lipid peroxidation discovered in recent years, and the main molecular mechanism involves dysregulation of iron homeostasis, mitochondrial dysfunction, impaired antioxidant capacity, and accumulation of lipid peroxides. In recent years, there has been increasing evidence that ferroptosis is involved in the pathophysiologic process of DOP. However, its exact role and potential molecular mechanisms have not been fully elucidated. In this paper, the role of ferroptosis in developing T2DM and osteoporosis is reviewed, with the intention of providing novel insights into the pathophysiologic investigation of DOP. Furthermore, possible therapeutic compounds that target the ferroptosis signaling system are presented, and ways for leveraging ferroptosis in the prevention and treatment of DOP are examined. These findings are anticipated to offer new directions for the therapeutic intervention and drug development for DOP.

Keywords: diabetic osteoporosis; ferroptosis; mitochondria; osteoporosis; type 2 diabetes mellitus.

PubMed Disclaimer

References

    1. A. L. Gloyn and D. J. Drucker, “Precision Medicine in the Management of Type 2 Diabetes,” Lancet Diabetes and Endocrinology 6 (2018): 891–900.
    1. Y. D. Liu, J. F. Liu, and B. Liu, “N,N‐Dimethylformamide Inhibits High Glucose‐Induced Osteoporosis via Attenuating MAPK and NF‐κB Signalling,” Bone & Joint Research 11 (2022): 200–209.
    1. S. Li, Y. Mao, F. Zhou, H. Yang, Q. Shi, and B. Meng, “Gut Microbiome and Osteoporosis: A Review,” Bone & Joint Research 9 (2020): 524–530.
    1. Y. Chen, W. Zhao, A. Hu, et al., “Type 2 Diabetic Mellitus Related Osteoporosis: Focusing on Ferroptosis,” Journal of Translational Medicine 22 (2024): 409.
    1. Z. Li, D. Li, R. Chen, S. Gao, Z. Xu, and N. Li, “Cell Death Regulation: A New Way for Natural Products to Treat Osteoporosis,” Pharmacological Research 187 (2023): 106635.

LinkOut - more resources